Professor Frances Boyle

AM
Professor of Medical Oncology & Director of Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital

Telephone +61 2 99577744
Fax +61 2 99540808

Curriculum vitae Curriculum vitae

Map

Selected grants

2016

  • SOFT and TEXT premenopausal randomised adjuvant endocrine breast cancer trials; Francis P, Boyle F; National Health and Medical Research Council (NHMRC)/Project Grants.

2015

  • Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatments and Risk Factors; Goldstein D, Park S, Friedlander M, Kiernan M, Krishnan A, Boyle F, Moalem-Taylor G, Haas M, Cohn R, Farrar M; Cancer Institute New South Wales/Translational Cancer Research Centre.
  • Breast cancer therapies that target IGFBP-3 signalling; Baxter R, Boyle F, Martin J; Cancer Council New South Wales/Research Project Grants.
  • Long-term Nerve Damage in Cancer Survivors: Identification of Risk Factors and Optimal Assessment Strategies; Park S, Krishnan A, Goldstein D, Friedlander M, Lin C, Kwok J, Kwok J, Boyle F, Horvath L, Haas M, Barnes E; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • Implementing a national clinical pathway for pain to ensure equitable, cost-effective, evidence-based, person-centred care for people with advanced breast and other cancers; Lovell M, Phillips J, Agar M, Boyle F, Davidson P, Luckett T, Currow D, Lam L, MacCaffrey N, Shaw T; National Breast Cancer Foundation/Translational Research Grants.
  • Northern Translational Cancer Research Centre (NTCRC); Engel A, Bailey D, Boyle F, Clarke S, Gill A, Marsh D, Nguyen S, Molloy M; Cancer Institute New South Wales/Translational Cancer Research Centre.
  • Scalp Cooling Collaboration Project; Shaw J, Butow P, Boyle F, Price M, Pugliano L, Winstanley J; St Vincents and Mater Health Sydney/Research Support.
  • Rekindle Sexuality After Cancer: Development and Testing of a Novel Web-Based Psychoeducational Resource for BOTH Survivors and their Partners; Lawsin C, Lawsin C, Butow P, Juraskova I, Lambert S, Kay J, McGeechan K, Boyle F, Batt G, Miller A, Brotto L, Ritterband L, Dhillon H; Australian Research Council (ARC)/Linkage Projects (LP).
  • Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor positive breast cancer; Francis P, Wilcken N, Murray N, Forbes J, Redfern A, Boyle F, Spillane A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Healthy Living after Cancer; Eakin E, Hayes S, Haas M, Reeves M, Vardy J, Boyle F, Hiller J, Mishra G, Jefford M; National Health and Medical Research Council (NHMRC)/Partnership Projects.

2012

  • Data Linkage for NSW Bioresources using CHeReL; Baxter R, Robinson B, Boyle F, Clarke C, Marsh D; Cancer Institute New South Wales/Biobanking Stakeholder Network Funding.
  • Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial; Vardy J, Tattersall M, Dhillon H, Bell M, Cysique L, Boyle F, Clarke S; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2011

  • Development of a Quality of Life Module specific to Melanoma; Winstanley J, Bergenmar M, Bottomley A, Garioch J, Constantine A, Koller M, van de Poll-Franse L, Steinbauer J, Boyle F, Thompson J, King M; European Organisation for Research and Treatment of Cancer (EORTC)/Research Support.

2010

  • Efficacy and safety of Gingko biloba for cognitive function in breast cancer patients undergoing adjuvant chemotherapy; Vardy J, Dhillon N, Boyle F; Friends of the Mater/Annual Grant.
  • Evaluation of a Web-based Cognitive Rehabilitation Programme in Cancer Survivors with Self Reported Cognitive Impairment; Bray V, Vardy J, Dhillon H, Boyle F; Friends of the Mater/Annual Grant.
  • Protein discovery for breast cancer diagnosis; Baxter R, Moore (Loveridge) K, Marsh D, Boyle F, McCarthy N; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • Improving informed consent: A randomised controlled trial of a decision aid for women invited to participate in IBIS-2; Butow P, Boyle F, Coates A, Forbes J; National Breast Cancer Foundation/Kathleen Cuningham Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Lovell, M., Boyle, F. (2013). Overcoming cancer pain: a guide for people with cancer, their families and friends. Australia: Cancer Council Australia.

Book Chapters

  • Blyth, F., Boyle, F. (2011). Cancer and chronic pain. Chronic Pain Epidemiology: From Aetiology to Public Health, (pp. 271-276). United Kingdom: Oxford University Press. [More Information]
  • Lovell, M., Boyle, F. (2010). Communication strategies and skills for optimal pain control. In David W Kissane, Barry D Bultz, Phyllis N Butow, Ilora G Finlay (Eds.), Handbook Of Communication In Oncology And Palliative Care, (pp. 315-326). Oxford, UK: Oxford University Press Australia.

Journals

  • Bray, V., Dhillon, H., Bell, M., Kabourakis, M., Fiero, M., Yip, D., Boyle, F., Price, M., Vardy, J. (2017). Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy. Journal of Clinical Oncology, 35(2), 217-225. [More Information]
  • Zdenkowski, N., Butow, P., Hutchings, E., Douglas, C., Coll, J., Boyle, F. (2016). A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO). JMIR Research Protocols, 5(2), 1-11. [More Information]
  • Zdenkowski, N., Butow, P., Mann, G., Fewster, S., Beckmore, C., Isaacs, R., Douglas, C., Boyle, F. (2016). A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer. Internal Medicine Journal, 46(6), 677-683. [More Information]
  • Zdenkowski, N., Butow, P., Tesson, S., Boyle, F. (2016). A systematic review of decision aids for patients making a decision about treatment for early breast cancer. The Breast, 26, 31-45. [More Information]
  • Piccart-Gebhart, M., Holmes, E., Baselga, J., De Azambuja, E., Dueck, A., Viale, G., Zujewski, J., Goldhirsch, A., Amour, A., Pritchard, K., Boyle, F., et al (2016). Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial. Journal of Clinical Oncology, 34(10), 1034-1042. [More Information]
  • Phillips, K., Regan, M., Ribi, K., Francis, P., Puglisi, F., Bellet, M., Spazzapan, S., Karlsson, P., Budman, D., Zaman, K., Coates, A., Boyle, F., et al (2016). Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British Journal of Cancer, 114(9), 956-964. [More Information]
  • Kemp-Casey, A., Roughead, E., Saunders, C., Boyle, F., Lopez, D., Bulsara, M., Preen, D. (2016). Breast cancer recurrence following active treatment: Determining its incidence in the NSW population. Public Health Research and Practice, 26(1), 1-8. [More Information]
  • Dong, S., Butow, P., Agar, M., Lovell, M., Boyle, F., Stockler, M., Forster, B., Tong, A. (2016). Clinicians’ Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study. Journal of Pain and Symptom Management, 51(4), 706-717.e5. [More Information]
  • Strasser-Weippl, K., Horick, N., Smith, I., O'Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., et al (2016). Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. European Journal of Cancer, 56, 85-92. [More Information]
  • Sonnenblick, A., de Azambuja, E., Agbor-tarh, D., Bradbury, I., Campbell, C., Huang, Y., Dueck, A., Pritchard, K., Boyle, F., et al (2016). Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial. Journal of the National Cancer Institute, 108(8), 1-8. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Boyle, F. (2016). Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning. Asia-Pacific Journal of Clinical Oncology, 12(2), e323-e331. [More Information]
  • Dong, S., Butow, P., Tong, A., Agar, M., Boyle, F., Forster, B., Stockler, M., Lovell, M. (2016). Patients' experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study. Supportive Care in Cancer, 24(3), 1373-1386. [More Information]
  • Shaw, J., Baylock, B., O'Reilly, A., Winstanley, J., Pugliano, L., Andrews, K., Boyle, F. (2016). Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Supportive Care in Cancer, 24(9), 3813-3820. [More Information]
  • Zdenkowsk, N., Tesson, S., Lombard, J., Lovell, M., Hayes, S., Francis, P., Dhillon, H., Boyle, F. (2016). Supportive care of women with breast cancer: key concerns and practical solutions. Medical Journal of Australia, 205(10), 471-475. [More Information]
  • Chung, L., Phillips, L., Lin, Z., Moore, K., Marsh, D., Boyle, F., Baxter, R. (2015). A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer. Cancer Letters, 368(1), 64-70. [More Information]
  • Bae, K., Yoo, H., Lamoury, G., Boyle, F., Rosenthal, D., Oh, B. (2015). Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review. Integrative Cancer Therapies, 14(6), 496-502. [More Information]
  • Lovell, M., Luckett, T., Boyle, F., Stubbs, J., Phillips, J., Davidson, P., Oliver, I., von Dincklage, J., Agar, M. (2015). Adaptation of international guidelines on assessment and management of cancer pain for the Australian context. Asia-Pacific Journal of Clinical Oncology, 11(2), 170-177. [More Information]
  • Butow, P., Brown, R., Aldridge, J., Juraskova, I., Zoller, P., Boyle, F., Wilson, M., Bernhard, J. (2015). Can consultation skills training change doctors’ behaviour to increase involvement of patients in making decisions about standard treatment and clinical trials: a randomized controlled trial. Health Expectations, 18(6), 2570-2583. [More Information]
  • Winstanley, J., Young, T., Boyle, F., Bergenmar, M., Bottomley, A., Burmeister, B., Campana, L., Garioch, J., King, M., Nikolic, D., Saw, R., Thompson, J., et al (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Research, 25, 47-58. [More Information]
  • Zdenkowski, N., Butow, P., Mann, B., Fewster, S., Douglas, C., Boyle, F. (2015). Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists. ANZ Journal of Surgery, 85(11), 797-799. [More Information]
  • Inglis, H., Boyle, F., Friedlander, M., Watson, S. (2015). Dry eyes and AIs: If you don't ask you won't find out. The Breast, 24(6), 694-698. [More Information]
  • Brennan, M., Boyle, F., Butow, P., Spillane, A. (2015). Evaluation of a survivorship care plan: long-term use, care coordination and quality of life in breast cancer survivors. Breast Cancer Management, 4(3), 145-157. [More Information]
  • Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. New England Journal of Medicine, 372(10), 923-932. [More Information]
  • Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. Obstetrical and Gynecological Survey, 70(6), 392-393. [More Information]
  • Boyle, F., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., Moy, B., Piccart-Gebhart, M., et al (2015). Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. European Journal of Cancer, 51(6), 685-696. [More Information]
  • Eakin, E., Hayes, S., Haas, M., Reeves, M., Vardy, J., Boyle, F., Hiller, J., Mishra, G., Goode, A., Jefford, M., White, K., et al (2015). Healthy Living after Cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors. BMC Cancer, 15(1), 1-11. [More Information]
  • Gelmon, K., Boyle, F., Kaufman, B., Huntsman, D., Manikhas, A., Di Leo, A., Martin, M., Schwartzberg, L., Lemieux, J., et al (2015). Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. Journal of Clinical Oncology, 33(14), 1574-1583. [More Information]
  • Strasser-Weippl, K., Horick, N., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., et al (2015). Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Research, 17(1), 1-7. [More Information]
  • van den Hurk, C., Winstanley, J., Young, A., Boyle, F. (2015). Measurement of chemotherapy-induced alopecia-time to change. Supportive Care in Cancer, 23(5), 1197-1199. [More Information]
  • Gedye, C., Boyle, F. (2015). Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually. Medical Journal of Australia, 202(3), 130-130. [More Information]
  • Read, R., Flitcroft, K., Snook, K., Boyle, F., Spillane, A. (2015). Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery, 85(5), 315-320. [More Information]
  • Tan, J., Butow, P., Boyle, F., Saw, R., O'Reilly, A. (2014). A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Research, 24(3), 252-260. [More Information]
  • Luckett, T., Davidson, P., Boyle, F., Winston, L., Agar, M., Green, A., Lovell, M. (2014). Australian survey of current practice and guideline use in adult cancer pain assessment and management: Perspectives of oncologists. Asia-Pacific Journal of Clinical Oncology, 10(2), e99-e107. [More Information]
  • Bowen, J., Mayo, B., Plews, E., Bateman, E., Wignall, A., Stringer, A., Boyle, F., Keefe, D. (2014). Determining the mechanisms of lapatinib-induced diarrhoea using a rat model. Cancer Chemotherapy and Pharmacology, 74(3), 617-627. [More Information]
  • Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., Roughead, E. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? SpringerPlus, 3(1), 1-10. [More Information]
  • Oh, B., Butow, P., Boyle, F., Beale, P., Costa, D., Pavlakis, N., Bell, D., Davis, E., Choi, S., Lee, M., Clarke, S., et al (2014). Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study. International Journal of Physical Medicine & Rehabilitation, 2(4), 1-6. [More Information]
  • Juraskova, I., Butow, P., Bonner, C., Bell, M., Smith, A., Seccombe, M., Boyle, F., Reaby, L., Cuzick, J., Forbes, J. (2014). Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial. British Journal of Cancer, 111(1), 1-17. [More Information]
  • De Azambuja, E., Holmes, A., Piccart-Gebhart, M., Holmes, E., Di Cosimo, S., Swaby, R., Untch, M., Jackisch, C., Lang, I., Smith, I., Boyle, F., et al (2014). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. The Lancet Oncology, 15(10), 1137-1146. [More Information]
  • McCarthy, N., Boyle, F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., Kannourakis, G., Francis, P., Chirgwin, J., Abdi, E., Gebski, V., Wilcken, N., et al (2014). Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). The Breast, 23(2), 142-151. [More Information]
  • Chung, L., Katrina, M., Phillips, L., Boyle, F., Marsh, D., Baxter, R. (2014). Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer Research, 16(3), 1-12. [More Information]
  • Lovell, M., Luckett, T., Boyle, F., Phillips, J., Agar, M., Davidson, P. (2014). Patient Education, Coaching, and Self-Management for Cancer Pain. Journal of Clinical Oncology, 32(16), 1712-1720. [More Information]
  • Gormally, J., Izard, M., Robinson, B., Boyle, F. (2014). Pituitary metastasis from breast cancer presenting as diabetes insipidus. BMJ Case Reports, 2014, 1-4. [More Information]
  • Brennan, M., Gormally, J., Butow, P., Boyle, F., Spillane, A. (2014). Survivorship care plans in cancer: a systematic review of care plan outcomes. British Journal of Cancer, 111(10), 1899-1908. [More Information]
  • Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Holman, D., Malacova, E., Roughead, E. (2014). Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice. PloS One, 9(1), 1-8. [More Information]
  • Luckett, T., Davidson, P., Green, A., Boyle, F., Stubbs, J., Lovell, M. (2013). Assessment and Management of Adult Cancer Pain: A Systematic Review and Synthesis of Recent Qualitative Studies Aimed at Developing Insights for Managing Barriers and Optimizing Facilitators Within a Comprehensive Framework of Patient Care. Journal of Pain and Symptom Management, 46(2), 229-253. [More Information]
  • Clayton, J., Butow, P., Waters, A., Laidsaar-Powell, R., O'Brien, A., Boyle, F., Back, A., Arnold, R., Tulsky, J., Tattersall, M. (2013). Evaluation of a novel individualised communication-skills training intervention to improve doctors' confidence and skills in end-of-life communication. Palliative Medicine, 27(3), 236-243. [More Information]
  • Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
  • Thewes, B., Bell, M., Butow, P., Beith, J., Boyle, F., Friedlander, M., McLachlan, S. (2013). Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psycho-Oncology, 22(12), 2797-2806. [More Information]
  • Stein, R., Sharpe, L., Bell, M., Boyle, F., Dunn, S., Clarke, S. (2013). Randomized Controlled Trial of a Structured Intervention to Facilitate End-of-Life Decision Making in Patients With Advanced Cancer. Journal of Clinical Oncology, 31(27), 3403-3410. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Chung, L., Shibli, S., Moore, K., Elder, E., Boyle, F., Marsh, D., Baxter, R. (2013). Tissue biomarkers of breast cancer and their association with conventional pathologic features. British Journal of Cancer, 108(2), 351-360. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]
  • Winstanley, J., White, E., Boyle, F., Thompson, J. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167-174. [More Information]
  • Goldstein, D., Bennett, B., Webber, K., Boyle, F., De Souza, P., Wilcken, N., Scott, E., Toppler, R., Murie, P., O'Malley, L., Hickie, I., et al (2012). Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study. Journal of Clinical Oncology, 30(15), 1805-1812. [More Information]
  • Bowen, J., Mayo, B., Plews, E., Bateman, E., Stringer, A., Boyle, F., Finnie, J., Keefe, D. (2012). Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea. Cancer Biology & Therapy, 13(13), 1269-1275. [More Information]
  • Cameron, B., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A. (2012). Post-cancer fatigue is not associated with immune activation or altered cytokine production. Annals of Oncology, 23(11), 2890-2895. [More Information]
  • Sung-In Jang, H., Spillane, A., Boyle, F., Fogarty, G. (2012). Radiotherapy can cause haemostasis in bleeding skin malignancies. Case Reports in Medicine, 2012, 168681- 1-168681- 4. [More Information]
  • Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011). A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment, 129(2), 467-476. [More Information]
  • Tolerton, S., Shaw, J., O'Reilly, A., Dunn, S., Boyle, F. (2011). Exploring consent to randomized placebo-controlled clinical trials in oncology. Asia-Pacific Journal of Clinical Oncology, 7(3), 300-306. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Marven, M., Boyle, F. (2011). Follow up after breast cancer - views of Australian women. Australian Family Physician, 40(5), 311-316. [More Information]
  • Brennan, M., Butow, P., Marven, M., Spillane, A., Boyle, F. (2011). Survivorship care after breast cancer treatment - Experiences and preferences of Australian women. The Breast, 20(3), 271-277. [More Information]
  • Lovell, M., Forder, P., Stockler, M., Butow, P., Briganti, E., Chye, R., Goldstein, D., Boyle, F. (2010). A Randomized Controlled Trial of a Standardized Educational Intervention for Patients with Cancer Pain. Journal of Pain and Symptom Management, 40(1), 49-59. [More Information]
  • Lovell, M., Boyle, F. (2010). Cancer Pain Management. Medicine Today, 11(1), 33-38.
  • Kaser, E., Shaw, J., Marven, M., Swinburn, L., Boyle, F. (2010). Communication about high-cost drugs in oncology-the patient view. Annals of Oncology, 21(9), 1910-1914. [More Information]
  • Schapira, L., Butow, P., Brown, R., Boyle, F. (2010). Pessimism Is No Poison. Journal of Clinical Oncology, 28(4), 705-707. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Boyle, F. (2010). Survivorship care after breast cancer: Follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia-Pacific Journal of Clinical Oncology, 6(2), 116-125. [More Information]
  • Snyder, R., Boyle, F., Chan, A., Craft, P., de Boer, R., Mainwaring, P., McCarthy, N., Wilcken, N. (2009). Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer. Asia-Pacific Journal of Clinical Oncology, 5(1), 4-16. [More Information]
  • Boyle, F. (2009). Multidisciplinary care: optimising team performance. Cancer Treatment and Research, 151, 93-101. [More Information]
  • Duric, V., Butow, P., Sharpe, L., Heritier, S., Boyle, F., Beith, J., Wilcken, N., Coates, A., Simes, R., Stockler, M. (2008). Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Education and Counseling, 72(2), 239-245. [More Information]
  • Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Coates, A., Boyle, F., McCarthy, N., Reaby, L., Forbes, J. (2008). Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expectations, 11(3), 252-262. [More Information]
  • Crown, J., Burris III, H., Boyle, F., Jones, S., Koehler, M., Newstat, B., Parikh, R., Oliva, C., Preston, A., Byrne, J., et al (2008). Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. Breast Cancer Research and Treatment, 112(2), 317-325. [More Information]
  • Butow, P., Tattersall, M., Boyle, F., Introna, K., Kearsley, J., Kristjanson, L., Martin, P., Meller, A., Mitchell, G., Moore, A., Olver, I., et al (2007). Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Medical Journal of Australia, 186(12), S77-S79. [More Information]
  • Murphy, S., Boyle, F., Davey, R., Gu, X., Mather, L. (2007). Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Journal of Pharmacy and Pharmacology, 59(1), 105-114. [More Information]
  • Murphy, S., Davey, R., Gu, X., Haywood, M., McCann, L., Mather, L., Boyle, F. (2007). Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Journal of Neuro-Oncology, 85(2), 181-189. [More Information]
  • Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Boyle, F., McCarthy, N., Forbes, J. (2007). Improving informed consent to clinical trials: Successful piloting of a decision aid. Journal of Clinical Oncology, 25(11), 1443-1444. [More Information]
  • Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., Simes, R., Stockler, M. (2007). Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology, 16(1), 48-59. [More Information]
  • Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., Simes, R., Stockler, M. (2007). Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology, 16(1), 48-59. [More Information]
  • Dalton, L., Luxford, K., Boyle, F., Goldstein, D., Underhill, C., Yates, P. (2006). An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy. Journal of Cancer Education, 21(1), 35-39. [More Information]
  • Brown, R., Butow, P., Boyle, F., Tattersall, M. (2006). Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psycho-Oncology, 16(6), 507-516. [More Information]
  • Murphy, S., Boyle, F., Gu, X., Mather, L. (2006). Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 831, 48-56. [More Information]
  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Heritier, S., Beith, J., Boyle, F., Wilcken, N., Coates, A., Simes, R. (2005). Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC). Journal of Clinical Oncology, 23(16S), 546S-546S.
  • Boyle, F., Robinson, E., Dunn, S., Heinrich, P. (2005). Multidisciplinary Care in Cancer: The Fellowship of the Ring. Journal of Clinical Oncology, 23(4), 916-920. [More Information]
  • Duric, V., Stockler, M., Heritier, S., Boyle, F., Beith, J., Sullivan, A., Wilcken, N., Coates, A., Simes, R. (2005). Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Annals of Oncology, 16(11), 1786-1794. [More Information]
  • Thewes, B., Meiser, B., Duric, V., Stockler, M., Taylor, A., Stuart-Harris, R., Links, M., Wilcken, N., McLachlan, S., Phillips, K., Boyle, F., et al (2005). What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncology, 6(8), 581-588. [More Information]
  • Boyle, F., Dunn, S., Robinson, E., Heinrich, P. (2004). Cancer: Communicating In The Team Game. ANZ Journal of Surgery, 74(6), 477-481. [More Information]
  • Brown, R., Butow, P., Sharrock, M., Henman, M., Boyle, F., Goldstein, D., Tattersall, M. (2004). Education And Role Modelling For Clinical Decisions With Female Cancer Patients. Health Expectations, 7(4), 303-316. [More Information]
  • Boyle, F., Scott, C., Ferrier, A., Baron-Hay, S. (2004). Elevated Serum Insulin-Like Growth Factor Binding Protein-2 As A Prognostic Marker In Patients With Ovarian Cancer. Clinical Cancer Research, 10(5), 1796-1806. [More Information]
  • Boyle, F., Eller, S., Grossman, S. (2004). Penetration Of Intra-Arterially Administered Vincristine In Experimental Brain Tumor. Neuro-Oncology, 6(4), 300-305. [More Information]
  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Beith, J., Sullivan, A., Boyle, F., Dhillon, H., Coates, A., Simes, R. (2004). Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC). Journal of Clinical Oncology, 22(14S), 73S-73S.
  • Brown, R., Butow, P., Ellis, P., Boyle, F., Tattersall, M. (2004). Seeking Informed Consent To Cancer Clinical Trials: Describing Current Practice. Social Science and Medicine, 58(12), 2445-2457. [More Information]
  • Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
  • Boyle, F., Dunn, S., Riches, J. (2003). More than one way to foster communication skills for medical oncology fellows: a national program in Australia. Journal of Clinical Oncology, 11. [More Information]
  • Potter, V., Wiseman, C., Dunn, S., Boyle, F. (2003). Patient barriers to optimal cancer pain control. Psycho-Oncology, 12(2), 153-160. [More Information]
  • Loh, W., Butow, P., Brown, R., Boyle, F. (2002). Ethical Communication in Clinical Trials: Issues Faced by Data Manager in Obtaining Informed Consent. Cancer, 95(11), 2414-2421. [More Information]
  • Henman, M., Butow, P., Brown, R., Boyle, F., Tattersall, M. (2002). Lay constructions of decision-making in cancer. Psycho-Oncology, 11(4), 295-306. [More Information]
  • Brown, R., Butow, P., Henman, M., Dunn, S., Boyle, F., Tattersall, M. (2002). Responding to the active and passive patient: flexibility is the key. Health Expectations, 5(3), 236-245. [More Information]

2017

  • Bray, V., Dhillon, H., Bell, M., Kabourakis, M., Fiero, M., Yip, D., Boyle, F., Price, M., Vardy, J. (2017). Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy. Journal of Clinical Oncology, 35(2), 217-225. [More Information]

2016

  • Zdenkowski, N., Butow, P., Hutchings, E., Douglas, C., Coll, J., Boyle, F. (2016). A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO). JMIR Research Protocols, 5(2), 1-11. [More Information]
  • Zdenkowski, N., Butow, P., Mann, G., Fewster, S., Beckmore, C., Isaacs, R., Douglas, C., Boyle, F. (2016). A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer. Internal Medicine Journal, 46(6), 677-683. [More Information]
  • Zdenkowski, N., Butow, P., Tesson, S., Boyle, F. (2016). A systematic review of decision aids for patients making a decision about treatment for early breast cancer. The Breast, 26, 31-45. [More Information]
  • Piccart-Gebhart, M., Holmes, E., Baselga, J., De Azambuja, E., Dueck, A., Viale, G., Zujewski, J., Goldhirsch, A., Amour, A., Pritchard, K., Boyle, F., et al (2016). Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial. Journal of Clinical Oncology, 34(10), 1034-1042. [More Information]
  • Phillips, K., Regan, M., Ribi, K., Francis, P., Puglisi, F., Bellet, M., Spazzapan, S., Karlsson, P., Budman, D., Zaman, K., Coates, A., Boyle, F., et al (2016). Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British Journal of Cancer, 114(9), 956-964. [More Information]
  • Kemp-Casey, A., Roughead, E., Saunders, C., Boyle, F., Lopez, D., Bulsara, M., Preen, D. (2016). Breast cancer recurrence following active treatment: Determining its incidence in the NSW population. Public Health Research and Practice, 26(1), 1-8. [More Information]
  • Dong, S., Butow, P., Agar, M., Lovell, M., Boyle, F., Stockler, M., Forster, B., Tong, A. (2016). Clinicians’ Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study. Journal of Pain and Symptom Management, 51(4), 706-717.e5. [More Information]
  • Strasser-Weippl, K., Horick, N., Smith, I., O'Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., et al (2016). Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. European Journal of Cancer, 56, 85-92. [More Information]
  • Sonnenblick, A., de Azambuja, E., Agbor-tarh, D., Bradbury, I., Campbell, C., Huang, Y., Dueck, A., Pritchard, K., Boyle, F., et al (2016). Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial. Journal of the National Cancer Institute, 108(8), 1-8. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Boyle, F. (2016). Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning. Asia-Pacific Journal of Clinical Oncology, 12(2), e323-e331. [More Information]
  • Dong, S., Butow, P., Tong, A., Agar, M., Boyle, F., Forster, B., Stockler, M., Lovell, M. (2016). Patients' experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study. Supportive Care in Cancer, 24(3), 1373-1386. [More Information]
  • Shaw, J., Baylock, B., O'Reilly, A., Winstanley, J., Pugliano, L., Andrews, K., Boyle, F. (2016). Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Supportive Care in Cancer, 24(9), 3813-3820. [More Information]
  • Zdenkowsk, N., Tesson, S., Lombard, J., Lovell, M., Hayes, S., Francis, P., Dhillon, H., Boyle, F. (2016). Supportive care of women with breast cancer: key concerns and practical solutions. Medical Journal of Australia, 205(10), 471-475. [More Information]

2015

  • Chung, L., Phillips, L., Lin, Z., Moore, K., Marsh, D., Boyle, F., Baxter, R. (2015). A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer. Cancer Letters, 368(1), 64-70. [More Information]
  • Bae, K., Yoo, H., Lamoury, G., Boyle, F., Rosenthal, D., Oh, B. (2015). Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review. Integrative Cancer Therapies, 14(6), 496-502. [More Information]
  • Lovell, M., Luckett, T., Boyle, F., Stubbs, J., Phillips, J., Davidson, P., Oliver, I., von Dincklage, J., Agar, M. (2015). Adaptation of international guidelines on assessment and management of cancer pain for the Australian context. Asia-Pacific Journal of Clinical Oncology, 11(2), 170-177. [More Information]
  • Butow, P., Brown, R., Aldridge, J., Juraskova, I., Zoller, P., Boyle, F., Wilson, M., Bernhard, J. (2015). Can consultation skills training change doctors’ behaviour to increase involvement of patients in making decisions about standard treatment and clinical trials: a randomized controlled trial. Health Expectations, 18(6), 2570-2583. [More Information]
  • Winstanley, J., Young, T., Boyle, F., Bergenmar, M., Bottomley, A., Burmeister, B., Campana, L., Garioch, J., King, M., Nikolic, D., Saw, R., Thompson, J., et al (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Research, 25, 47-58. [More Information]
  • Zdenkowski, N., Butow, P., Mann, B., Fewster, S., Douglas, C., Boyle, F. (2015). Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists. ANZ Journal of Surgery, 85(11), 797-799. [More Information]
  • Inglis, H., Boyle, F., Friedlander, M., Watson, S. (2015). Dry eyes and AIs: If you don't ask you won't find out. The Breast, 24(6), 694-698. [More Information]
  • Brennan, M., Boyle, F., Butow, P., Spillane, A. (2015). Evaluation of a survivorship care plan: long-term use, care coordination and quality of life in breast cancer survivors. Breast Cancer Management, 4(3), 145-157. [More Information]
  • Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. New England Journal of Medicine, 372(10), 923-932. [More Information]
  • Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. Obstetrical and Gynecological Survey, 70(6), 392-393. [More Information]
  • Boyle, F., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., Moy, B., Piccart-Gebhart, M., et al (2015). Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. European Journal of Cancer, 51(6), 685-696. [More Information]
  • Eakin, E., Hayes, S., Haas, M., Reeves, M., Vardy, J., Boyle, F., Hiller, J., Mishra, G., Goode, A., Jefford, M., White, K., et al (2015). Healthy Living after Cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors. BMC Cancer, 15(1), 1-11. [More Information]
  • Gelmon, K., Boyle, F., Kaufman, B., Huntsman, D., Manikhas, A., Di Leo, A., Martin, M., Schwartzberg, L., Lemieux, J., et al (2015). Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. Journal of Clinical Oncology, 33(14), 1574-1583. [More Information]
  • Strasser-Weippl, K., Horick, N., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., et al (2015). Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Research, 17(1), 1-7. [More Information]
  • van den Hurk, C., Winstanley, J., Young, A., Boyle, F. (2015). Measurement of chemotherapy-induced alopecia-time to change. Supportive Care in Cancer, 23(5), 1197-1199. [More Information]
  • Gedye, C., Boyle, F. (2015). Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually. Medical Journal of Australia, 202(3), 130-130. [More Information]
  • Read, R., Flitcroft, K., Snook, K., Boyle, F., Spillane, A. (2015). Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery, 85(5), 315-320. [More Information]

2014

  • Tan, J., Butow, P., Boyle, F., Saw, R., O'Reilly, A. (2014). A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Research, 24(3), 252-260. [More Information]
  • Luckett, T., Davidson, P., Boyle, F., Winston, L., Agar, M., Green, A., Lovell, M. (2014). Australian survey of current practice and guideline use in adult cancer pain assessment and management: Perspectives of oncologists. Asia-Pacific Journal of Clinical Oncology, 10(2), e99-e107. [More Information]
  • Bowen, J., Mayo, B., Plews, E., Bateman, E., Wignall, A., Stringer, A., Boyle, F., Keefe, D. (2014). Determining the mechanisms of lapatinib-induced diarrhoea using a rat model. Cancer Chemotherapy and Pharmacology, 74(3), 617-627. [More Information]
  • Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., Roughead, E. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? SpringerPlus, 3(1), 1-10. [More Information]
  • Oh, B., Butow, P., Boyle, F., Beale, P., Costa, D., Pavlakis, N., Bell, D., Davis, E., Choi, S., Lee, M., Clarke, S., et al (2014). Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study. International Journal of Physical Medicine & Rehabilitation, 2(4), 1-6. [More Information]
  • Juraskova, I., Butow, P., Bonner, C., Bell, M., Smith, A., Seccombe, M., Boyle, F., Reaby, L., Cuzick, J., Forbes, J. (2014). Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial. British Journal of Cancer, 111(1), 1-17. [More Information]
  • De Azambuja, E., Holmes, A., Piccart-Gebhart, M., Holmes, E., Di Cosimo, S., Swaby, R., Untch, M., Jackisch, C., Lang, I., Smith, I., Boyle, F., et al (2014). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. The Lancet Oncology, 15(10), 1137-1146. [More Information]
  • McCarthy, N., Boyle, F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., Kannourakis, G., Francis, P., Chirgwin, J., Abdi, E., Gebski, V., Wilcken, N., et al (2014). Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). The Breast, 23(2), 142-151. [More Information]
  • Chung, L., Katrina, M., Phillips, L., Boyle, F., Marsh, D., Baxter, R. (2014). Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer Research, 16(3), 1-12. [More Information]
  • Lovell, M., Luckett, T., Boyle, F., Phillips, J., Agar, M., Davidson, P. (2014). Patient Education, Coaching, and Self-Management for Cancer Pain. Journal of Clinical Oncology, 32(16), 1712-1720. [More Information]
  • Gormally, J., Izard, M., Robinson, B., Boyle, F. (2014). Pituitary metastasis from breast cancer presenting as diabetes insipidus. BMJ Case Reports, 2014, 1-4. [More Information]
  • Brennan, M., Gormally, J., Butow, P., Boyle, F., Spillane, A. (2014). Survivorship care plans in cancer: a systematic review of care plan outcomes. British Journal of Cancer, 111(10), 1899-1908. [More Information]
  • Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Holman, D., Malacova, E., Roughead, E. (2014). Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice. PloS One, 9(1), 1-8. [More Information]

2013

  • Luckett, T., Davidson, P., Green, A., Boyle, F., Stubbs, J., Lovell, M. (2013). Assessment and Management of Adult Cancer Pain: A Systematic Review and Synthesis of Recent Qualitative Studies Aimed at Developing Insights for Managing Barriers and Optimizing Facilitators Within a Comprehensive Framework of Patient Care. Journal of Pain and Symptom Management, 46(2), 229-253. [More Information]
  • Clayton, J., Butow, P., Waters, A., Laidsaar-Powell, R., O'Brien, A., Boyle, F., Back, A., Arnold, R., Tulsky, J., Tattersall, M. (2013). Evaluation of a novel individualised communication-skills training intervention to improve doctors' confidence and skills in end-of-life communication. Palliative Medicine, 27(3), 236-243. [More Information]
  • Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
  • Lovell, M., Boyle, F. (2013). Overcoming cancer pain: a guide for people with cancer, their families and friends. Australia: Cancer Council Australia.
  • Thewes, B., Bell, M., Butow, P., Beith, J., Boyle, F., Friedlander, M., McLachlan, S. (2013). Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psycho-Oncology, 22(12), 2797-2806. [More Information]
  • Stein, R., Sharpe, L., Bell, M., Boyle, F., Dunn, S., Clarke, S. (2013). Randomized Controlled Trial of a Structured Intervention to Facilitate End-of-Life Decision Making in Patients With Advanced Cancer. Journal of Clinical Oncology, 31(27), 3403-3410. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Chung, L., Shibli, S., Moore, K., Elder, E., Boyle, F., Marsh, D., Baxter, R. (2013). Tissue biomarkers of breast cancer and their association with conventional pathologic features. British Journal of Cancer, 108(2), 351-360. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]
  • Winstanley, J., White, E., Boyle, F., Thompson, J. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167-174. [More Information]

2012

  • Goldstein, D., Bennett, B., Webber, K., Boyle, F., De Souza, P., Wilcken, N., Scott, E., Toppler, R., Murie, P., O'Malley, L., Hickie, I., et al (2012). Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study. Journal of Clinical Oncology, 30(15), 1805-1812. [More Information]
  • Bowen, J., Mayo, B., Plews, E., Bateman, E., Stringer, A., Boyle, F., Finnie, J., Keefe, D. (2012). Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea. Cancer Biology & Therapy, 13(13), 1269-1275. [More Information]
  • Cameron, B., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A. (2012). Post-cancer fatigue is not associated with immune activation or altered cytokine production. Annals of Oncology, 23(11), 2890-2895. [More Information]
  • Sung-In Jang, H., Spillane, A., Boyle, F., Fogarty, G. (2012). Radiotherapy can cause haemostasis in bleeding skin malignancies. Case Reports in Medicine, 2012, 168681- 1-168681- 4. [More Information]

2011

  • Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011). A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment, 129(2), 467-476. [More Information]
  • Blyth, F., Boyle, F. (2011). Cancer and chronic pain. Chronic Pain Epidemiology: From Aetiology to Public Health, (pp. 271-276). United Kingdom: Oxford University Press. [More Information]
  • Tolerton, S., Shaw, J., O'Reilly, A., Dunn, S., Boyle, F. (2011). Exploring consent to randomized placebo-controlled clinical trials in oncology. Asia-Pacific Journal of Clinical Oncology, 7(3), 300-306. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Marven, M., Boyle, F. (2011). Follow up after breast cancer - views of Australian women. Australian Family Physician, 40(5), 311-316. [More Information]
  • Brennan, M., Butow, P., Marven, M., Spillane, A., Boyle, F. (2011). Survivorship care after breast cancer treatment - Experiences and preferences of Australian women. The Breast, 20(3), 271-277. [More Information]

2010

  • Lovell, M., Forder, P., Stockler, M., Butow, P., Briganti, E., Chye, R., Goldstein, D., Boyle, F. (2010). A Randomized Controlled Trial of a Standardized Educational Intervention for Patients with Cancer Pain. Journal of Pain and Symptom Management, 40(1), 49-59. [More Information]
  • Lovell, M., Boyle, F. (2010). Cancer Pain Management. Medicine Today, 11(1), 33-38.
  • Kaser, E., Shaw, J., Marven, M., Swinburn, L., Boyle, F. (2010). Communication about high-cost drugs in oncology-the patient view. Annals of Oncology, 21(9), 1910-1914. [More Information]
  • Lovell, M., Boyle, F. (2010). Communication strategies and skills for optimal pain control. In David W Kissane, Barry D Bultz, Phyllis N Butow, Ilora G Finlay (Eds.), Handbook Of Communication In Oncology And Palliative Care, (pp. 315-326). Oxford, UK: Oxford University Press Australia.
  • Schapira, L., Butow, P., Brown, R., Boyle, F. (2010). Pessimism Is No Poison. Journal of Clinical Oncology, 28(4), 705-707. [More Information]
  • Brennan, M., Butow, P., Spillane, A., Boyle, F. (2010). Survivorship care after breast cancer: Follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia-Pacific Journal of Clinical Oncology, 6(2), 116-125. [More Information]

2009

  • Snyder, R., Boyle, F., Chan, A., Craft, P., de Boer, R., Mainwaring, P., McCarthy, N., Wilcken, N. (2009). Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer. Asia-Pacific Journal of Clinical Oncology, 5(1), 4-16. [More Information]
  • Boyle, F. (2009). Multidisciplinary care: optimising team performance. Cancer Treatment and Research, 151, 93-101. [More Information]

2008

  • Duric, V., Butow, P., Sharpe, L., Heritier, S., Boyle, F., Beith, J., Wilcken, N., Coates, A., Simes, R., Stockler, M. (2008). Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Education and Counseling, 72(2), 239-245. [More Information]
  • Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Coates, A., Boyle, F., McCarthy, N., Reaby, L., Forbes, J. (2008). Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expectations, 11(3), 252-262. [More Information]
  • Crown, J., Burris III, H., Boyle, F., Jones, S., Koehler, M., Newstat, B., Parikh, R., Oliva, C., Preston, A., Byrne, J., et al (2008). Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. Breast Cancer Research and Treatment, 112(2), 317-325. [More Information]

2007

  • Butow, P., Tattersall, M., Boyle, F., Introna, K., Kearsley, J., Kristjanson, L., Martin, P., Meller, A., Mitchell, G., Moore, A., Olver, I., et al (2007). Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Medical Journal of Australia, 186(12), S77-S79. [More Information]
  • Murphy, S., Boyle, F., Davey, R., Gu, X., Mather, L. (2007). Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Journal of Pharmacy and Pharmacology, 59(1), 105-114. [More Information]
  • Murphy, S., Davey, R., Gu, X., Haywood, M., McCann, L., Mather, L., Boyle, F. (2007). Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Journal of Neuro-Oncology, 85(2), 181-189. [More Information]
  • Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Boyle, F., McCarthy, N., Forbes, J. (2007). Improving informed consent to clinical trials: Successful piloting of a decision aid. Journal of Clinical Oncology, 25(11), 1443-1444. [More Information]
  • Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., Simes, R., Stockler, M. (2007). Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology, 16(1), 48-59. [More Information]
  • Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., Simes, R., Stockler, M. (2007). Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology, 16(1), 48-59. [More Information]

2006

  • Dalton, L., Luxford, K., Boyle, F., Goldstein, D., Underhill, C., Yates, P. (2006). An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy. Journal of Cancer Education, 21(1), 35-39. [More Information]
  • Brown, R., Butow, P., Boyle, F., Tattersall, M. (2006). Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psycho-Oncology, 16(6), 507-516. [More Information]
  • Murphy, S., Boyle, F., Gu, X., Mather, L. (2006). Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 831, 48-56. [More Information]

2005

  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Heritier, S., Beith, J., Boyle, F., Wilcken, N., Coates, A., Simes, R. (2005). Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC). Journal of Clinical Oncology, 23(16S), 546S-546S.
  • Boyle, F., Robinson, E., Dunn, S., Heinrich, P. (2005). Multidisciplinary Care in Cancer: The Fellowship of the Ring. Journal of Clinical Oncology, 23(4), 916-920. [More Information]
  • Duric, V., Stockler, M., Heritier, S., Boyle, F., Beith, J., Sullivan, A., Wilcken, N., Coates, A., Simes, R. (2005). Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Annals of Oncology, 16(11), 1786-1794. [More Information]
  • Thewes, B., Meiser, B., Duric, V., Stockler, M., Taylor, A., Stuart-Harris, R., Links, M., Wilcken, N., McLachlan, S., Phillips, K., Boyle, F., et al (2005). What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncology, 6(8), 581-588. [More Information]

2004

  • Boyle, F., Dunn, S., Robinson, E., Heinrich, P. (2004). Cancer: Communicating In The Team Game. ANZ Journal of Surgery, 74(6), 477-481. [More Information]
  • Brown, R., Butow, P., Sharrock, M., Henman, M., Boyle, F., Goldstein, D., Tattersall, M. (2004). Education And Role Modelling For Clinical Decisions With Female Cancer Patients. Health Expectations, 7(4), 303-316. [More Information]
  • Boyle, F., Scott, C., Ferrier, A., Baron-Hay, S. (2004). Elevated Serum Insulin-Like Growth Factor Binding Protein-2 As A Prognostic Marker In Patients With Ovarian Cancer. Clinical Cancer Research, 10(5), 1796-1806. [More Information]
  • Boyle, F., Eller, S., Grossman, S. (2004). Penetration Of Intra-Arterially Administered Vincristine In Experimental Brain Tumor. Neuro-Oncology, 6(4), 300-305. [More Information]
  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Beith, J., Sullivan, A., Boyle, F., Dhillon, H., Coates, A., Simes, R. (2004). Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC). Journal of Clinical Oncology, 22(14S), 73S-73S.
  • Brown, R., Butow, P., Ellis, P., Boyle, F., Tattersall, M. (2004). Seeking Informed Consent To Cancer Clinical Trials: Describing Current Practice. Social Science and Medicine, 58(12), 2445-2457. [More Information]

2003

  • Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
  • Boyle, F., Dunn, S., Riches, J. (2003). More than one way to foster communication skills for medical oncology fellows: a national program in Australia. Journal of Clinical Oncology, 11. [More Information]
  • Potter, V., Wiseman, C., Dunn, S., Boyle, F. (2003). Patient barriers to optimal cancer pain control. Psycho-Oncology, 12(2), 153-160. [More Information]

2002

  • Loh, W., Butow, P., Brown, R., Boyle, F. (2002). Ethical Communication in Clinical Trials: Issues Faced by Data Manager in Obtaining Informed Consent. Cancer, 95(11), 2414-2421. [More Information]
  • Henman, M., Butow, P., Brown, R., Boyle, F., Tattersall, M. (2002). Lay constructions of decision-making in cancer. Psycho-Oncology, 11(4), 295-306. [More Information]
  • Brown, R., Butow, P., Henman, M., Dunn, S., Boyle, F., Tattersall, M. (2002). Responding to the active and passive patient: flexibility is the key. Health Expectations, 5(3), 236-245. [More Information]

To update your profile click here. For support on your academic profile contact .